http://www.bing.com/news/search?q=sandoz&setmkt=en-US&FORM=BNFD&format=rssSearch resultshttp://www.bing.com/rsslogo.gifhttp://www.bing.com/news/search?q=sandoz&setmkt=en-US&FORM=BNFD&format=rssCopyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.yahoo.com%2fnews%2fnovartis-completes-sandoz-spinoff-052005241.html&c=3973679766623702464&mkt=en-us(Reuters) -Sandoz shares dipped on their market debut on Wednesday after the generic and biosimilar drugmaker was valued at a lower-than-expected 10.3 billion Swiss francs ($11.2 billion) in its ...Wed, 04 Oct 2023 02:42:00 GMTYahoohttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.thepharmaletter.com%2fbiosimilars-news%2fsandoz-steps-up-in-house-biosimilar-capabilities&c=14921655558605414527&mkt=en-usSwitzerland-based Sandoz , a leader in affordable medicines, today inaugurated a new biosimilar development center in Ljubljana, Slovenia, to strengthen and expand its in house biosimilar capabilities ...Wed, 17 Jun 2026 03:36:00 GMTThe Pharma Letterhttp://www.bing.com/th?id=ONUT.smK0n2XfTUjZK2AvXUOkRQ&pid=Newsw={0}&h={1}&c=14700466http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2ffinance.yahoo.com%2fnews%2fsandoz-group-still-attractive-43-011540595.html&c=2418566781241847575&mkt=en-usEver wondered if Sandoz Group stock could be a hidden value play, or if you're just jumping in after the most exciting moves? Let's find out what might actually be under the hood. After a rocky 2.4% ...Wed, 19 Nov 2025 16:00:00 GMTYahoo Financehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fsandoz-lifts-guidance-after-humira-biosimilar-assists-another-quarter-sales-growth&c=13633230181435827363&mkt=en-usNovartis spinout Sandoz garnered $2.6 billion in second-quarter product sales. After the performance, the company raised its sales guidance for the year. (Photo by Sebastian Kahnert/picture alliance ...Fri, 09 Aug 2024 00:49:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.mmm-online.com%2fhome%2fchannel%2fsandoz-buys-cimerli-from-coherus-biosimilar%2f&c=15002287886173753220&mkt=en-usSandoz bought the Cimerli (ranibizumab-eqrn) business from Coherus Biosciences, the companies announced Monday morning. In January, Sandoz and Coherus entered into an agreement on a $170 million cash ...Sun, 03 Mar 2024 16:00:00 GMTMM&Mhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fsandoz-spinoff-finally-here-novartis-gets-ball-rolling-strategic-review&c=4905909731002522531&mkt=en-usAmid U.S. generics pricing pressure, Novartis has been focusing Sandoz on biosimilars and complex generics while granting the unit autonomy within the group. (Novartis) () When Novartis unveiled a ...Mon, 25 Oct 2021 22:05:00 GMTFiercePharmahttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2ffinance.yahoo.com%2fnews%2fsandoz-ceo-speaking-44th-annual-214830210.html&c=4762546904233960013&mkt=en-usThe above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...Sun, 11 Jan 2026 16:00:00 GMTYahoo Financehttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.cnbc.com%2f2023%2f10%2f04%2fnovartis-unit-sandoz-completes-spinoff.html&c=18227629803047278960&mkt=en-usThe Swiss drugmaker announced intentions to spin off the Sandoz business in August, offering stakeholders one Sandoz share for every five Novartis shares via a dividend-in-kind distribution. Novartis ...Tue, 03 Oct 2023 22:51:00 GMTCNBChttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fdrugstorenews.com%2fsandoz-files-anti-dumping-complaint-about-chinese-antibiotics-imports&c=986837739463368604&mkt=en-usSandoz said sustained below-cost pricing, state subsidies and the concentration of global manufacturing capacity in China are among the market-distorting practices cited in a Reuters report.Tue, 09 Jun 2026 08:14:00 GMTDrug Store Newshttp://www.bing.com/th?id=ONUT.8xL3LEAv-Bpz0vgbWKjUUA&pid=Newsw={0}&h={1}&c=141440959http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fdrugstorenews.com%2fsandoz-inks-license-agreement-henlius-yervoy-biosimilar&c=9030945214291104226&mkt=en-usSandoz has signed a global collaboration agreement with Shanghai Henlius Biotech to commercialize a biosimilar of oncology therapy, ipilimumab (Bristol-Myers Squibb’s Yervoy). The agreement is for a ...Mon, 28 Apr 2025 17:00:00 GMTDrug Store Newshttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.benzinga.com%2fmarkets%2fequities%2f23%2f09%2f34609083%2fsandoz-pushes-product-launch-plans-as-novartis-shareholders-approve-the-spin-off&c=1153122458372216786&mkt=en-usAt an Extraordinary General Meeting, Novartis AG's (NYSE:NVS) shareholders approved the proposed 100% spin-off of Sandoz. Novartis shareholders and Novartis ADR holders will receive one Sandoz share ...Thu, 14 Sep 2023 23:54:00 GMTBenzinga.comhttp://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=6a35291676e14c198f0af747af863848&url=https%3a%2f%2fwww.nasdaq.com%2farticles%2fsandoz-to-invest-eur-150-mln-in-austrian-facility-to-strengthen-antibiotics-manufacturing&c=999257585737369691&mkt=en-us(RTTNews) - Sandoz, Novartis AG's (NVS) generics and biosimilars division, announced Monday plans for a joint investment with Austrian federal government for large-scale manufacture of active ...Mon, 27 Jul 2020 01:43:00 GMTNasdaq